Managing lymphoproliferative disorders in patients with rheumatoid arthritis

arthritis patient clutches hand

Lymphoproliferative disorders (LPDs) are characterised by the abnormal proliferation of lymphocytes – a white blood cell in the immune system. LPDs are a notable complication during the treatment of rheumatoid arthritis (RA), an autoimmune condition. In Japan, the incidence of LPDs in RA patients is high and the management and treatment strategies for these patients has been challenging. Dr Masao Tanaka from the Kyoto University […]

Read More… from Managing lymphoproliferative disorders in patients with rheumatoid arthritis

Off-the-shelf immunotherapy could lead to more accessible cancer treatment

Off-the-shelf immunotherapy could lead to more accessible cancer treatmen

Immunotherapy is a type of cancer treatment that harnesses the immune system to destroy cancerous cells. Dr Li Zhang and colleagues at Toronto General Hospital Research Institute and the University of Toronto, are pioneering a new type of “off-the-shelf” treatment using a type of immune cell—a double negative T (DNT) cell. Dr Zhang‘s work shows that DNT cells are a […]

Read More… from Off-the-shelf immunotherapy could lead to more accessible cancer treatment